83 related articles for article (PubMed ID: 2074444)
1. A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma: a Southwest Oncology Group study.
Whitehead RP; Fleming T; Macdonald JS; Goodman PJ; Neefe J; Braun TJ; Swinnen LJ; Hersh EM
J Biol Response Mod; 1990 Dec; 9(6):588-91. PubMed ID: 2074444
[TBL] [Abstract][Full Text] [Related]
2. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
3. Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.
Atkins MB; Robertson MJ; Gordon M; Lotze MT; DeCoste M; DuBois JS; Ritz J; Sandler AB; Edington HD; Garzone PD; Mier JW; Canning CM; Battiato L; Tahara H; Sherman ML
Clin Cancer Res; 1997 Mar; 3(3):409-17. PubMed ID: 9815699
[TBL] [Abstract][Full Text] [Related]
4. Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors.
Murren J; Modiano M; Clairmont C; Lambert P; Savaraj N; Doyle T; Sznol M
Clin Cancer Res; 2003 Sep; 9(11):4092-100. PubMed ID: 14519631
[TBL] [Abstract][Full Text] [Related]
5. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
[TBL] [Abstract][Full Text] [Related]
6. Phase I clinical trial and pharmacokinetic study of the spicamycin analog KRN5500 administered as a 1-hour intravenous infusion for five consecutive days to patients with refractory solid tumors.
Supko JG; Eder JP; Ryan DP; Seiden MV; Lynch TJ; Amrein PC; Kufe DW; Clark JW
Clin Cancer Res; 2003 Nov; 9(14):5178-86. PubMed ID: 14613997
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of 5-fluorouracil and high-dose leucovorin in recurrent adenocarcinoma of the cervix: a Gynecologic Oncology Group study.
Look KY; Blessing JA; Valea FA; McGehee R; Manetta A; Webster KD; Andersen WA
Gynecol Oncol; 1997 Dec; 67(3):255-8. PubMed ID: 9441772
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of recombinant human tumor necrosis factor in colorectal carcinoma.
Schaadt M; Pfreundschuh M; Lorscheidt G; Peters KM; Steinmetz T; Diehl V
J Biol Response Mod; 1990 Apr; 9(2):247-50. PubMed ID: 2341863
[TBL] [Abstract][Full Text] [Related]
9. Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy.
Hallahan DE; Vokes EE; Rubin SJ; O'Brien S; Samuels B; Vijaykumar S; Kufe DW; Phillips R; Weichselbaum RR
Cancer J Sci Am; 1995; 1(3):204-9. PubMed ID: 9166477
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial of simultaneous administration of interleukin 2 and interleukin 4 subcutaneously.
Whitehead RP; Friedman KD; Clark DA; Pagani K; Rapp L
Clin Cancer Res; 1995 Oct; 1(10):1145-52. PubMed ID: 9815906
[TBL] [Abstract][Full Text] [Related]
11. [Effect of intravenous treatment with tumor necrosis factor alpha in patients with advanced cancer--phase I clinical trials].
Muc M; Baranowski M
Przegl Lek; 1995; 52(10):496-8. PubMed ID: 8834840
[TBL] [Abstract][Full Text] [Related]
12. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel and 5-fluorouracil in metastatic breast cancer: the US experience.
Paul DM; Garrett AM; Meshad M; DeVore RD; Porter LL; Johnson DH
Semin Oncol; 1996 Feb; 23(1 Suppl 1):48-52. PubMed ID: 8629038
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
Ajani JA; Ilson DH; Kelsen DP
Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of oral S-1 for treatment of metastatic colorectal carcinoma.
Shirao K; Ohtsu A; Takada H; Mitachi Y; Hirakawa K; Horikoshi N; Okamura T; Hirata K; Saitoh S; Isomoto H; Satoh A
Cancer; 2004 Jun; 100(11):2355-61. PubMed ID: 15160338
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
Hudes GR; Lipsitz S; Grem J; Morrisey M; Weiner L; Kugler JW; Benson A
Cancer; 1999 Jan; 85(2):290-4. PubMed ID: 10023694
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of recombinant human interleukin-4 for advanced or recurrent non-small cell lung cancer.
Vokes EE; Figlin R; Hochster H; Lotze M; Rybak ME
Cancer J Sci Am; 1998; 4(1):46-51. PubMed ID: 9467046
[TBL] [Abstract][Full Text] [Related]
18. Phase II multicenter, randomized, double-blind study of recombinant mutated human tumor necrosis factor-α in combination with chemotherapies in cancer patients.
Li M; Xu T; Zhang Z; Xue X; Zhang C; Qin X; Li W; Hao Q; Zhang W; Zhang Y
Cancer Sci; 2012 Feb; 103(2):288-95. PubMed ID: 22085427
[TBL] [Abstract][Full Text] [Related]
19. Local treatment of liver metastases with recombinant tumour necrosis factor (rTNF): a phase one study.
IJzermans JN; van der Schelling GP; Scheringa M; Splinter TA; Marquet RL; Jeekel J
Neth J Surg; 1991 Aug; 43(4):121-5. PubMed ID: 1944989
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor in advanced colorectal cancer: a phase II study. A trial of the phase I/II study group of the Association for Medical Oncology of the German Cancer Society.
Heim ME; Siegmund R; Illiger HJ; Klee M; Rieche K; Berdel WE; Edler L
Onkologie; 1990 Dec; 13(6):444-7. PubMed ID: 2092281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
